Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 225,734 | 63,874 | 59,271 | 37,153 | 38,776 |
| Receivables | 831 | 361 | 295 | 197 | 163 |
| TOTAL | $227,630 | $65,122 | $60,273 | $37,863 | $39,218 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 53 | 66 | 80 | 93 | 108 |
| TOTAL | $53 | $66 | $80 | $93 | $108 |
| Total Assets | $227,683 | $65,188 | $60,353 | $37,956 | $39,325 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,734 | 1,072 | 1,609 | 381 | 390 |
| TOTAL | $2,794 | $1,135 | $1,670 | $437 | $444 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $12 | $30 | $45 | $62 |
| Total Liabilities | $2,794 | $1,147 | $1,699 | $483 | $506 |
| Shareholders' Equity | |||||
| Common Shares | 266,616 | 98,107 | 88,111 | 65,005 | 62,603 |
| Retained earnings | -47,089 | -38,837 | -33,299 | -30,722 | -25,941 |
| Other shareholders' equity | 5,362 | 4,772 | 3,841 | 3,190 | 2,157 |
| TOTAL | $224,889 | $64,041 | $58,654 | $37,473 | $38,819 |
| Total Liabilities And Equity | $227,683 | $65,188 | $60,353 | $37,956 | $39,325 |